NCT04961281View on ClinicalTrials.gov

Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 22, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

August 1, 2022

Conditions
Chronic PainCarpal Tunnel Syndrome
Interventions
DRUG

Dexmedetomidine

injection of Dexmedetomidine ( 10 microgram/kg) + 10 cc saline injection nearby median nerve as hydro-dissection

DRUG

Triamcinolone

injection of triamcinolone ( 40 mg) + 10 cc saline injection nearby median nerve as hydro-dissection

Trial Locations (1)

71111

Emad Zarief Kamel Said, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04961281 - Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome | Biotech Hunter | Biotech Hunter